AI assistant
Opthea Ltd — Director's Dealing 2018
Nov 29, 2018
32698_rns_2018-11-29_ef3421b8-b8a1-4e46-bbaf-7985af6946e4.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Opthea Limited ABN 32 006 340 567
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Geoffrey Kempler |
|---|---|
| Date of last notice | 9 May 2017 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. | **Sandhurst Trustees Ltd:**the registeredholder as nominee on behalf of GeoffreyKempler as beneficiary;**Baywick Pty Ltd:**Geoffrey Kempler is asubstantial shareholder. |
| Date of change | 29 November 2018 |
| No. of securities held prior to change | 615,246 fully paid ordinary shares.285,714 listed options, exercise price $0.27,expiry 25 November 2018.2,o00,000 unquoted options to purchaseordinary shares at an exercise priceof$0.48,exerciseperiod commencingon 30 June 2016, ending on 7 March 2021subject to vesting conditions. |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Class | Ordinary shares, fully paid.Unquoted options to acquire fully paidordinary shares. |
|---|---|
| Number acquired | 285,714 ordinary shares fully paid |
| Number disposed | Nil |
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | $0.27 per share |
| No. of securities held after change | 900,960 fully paid ordinary shares.2,o00,000 unquoted options to purchaseordinary shares at an exercise priceof$0.48,exerciseperiod commencingon 30 June 2016, ending on 7 March 2021subject to vesting conditions. |
| Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back | Issue of ordinary shares pursuant to theexercise of listed options at $0.27 pershare. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder(if issued securities) | N/A |
| Date of change | N/A |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation | N/A |
|---|---|
| Interest after change | N/A |
Part 3 –[+] Closed period
| art 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed abovetraded during a+closed period where prior written clearancewas required? | N/A |
| If so, was prior written clearance provided to allow the trade toproceed during this period? | N/A |
| If prior written clearance was provided, on what date was thisprovided? | N/A |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3